The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utilizing EMR capabilities to improve shared decision-making regarding DPYD pharmacogenomic testing.
 
Khalid Jazieh
Stock and Other Ownership Interests - Innovative Healthcare Institute (I)
Research Funding - Natera (I)
 
Jessica Wright
No Relationships to Disclose
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Lilly (Inst)
 
Joseph Sutton
No Relationships to Disclose
 
Benjamin Anderson
(OPTIONAL) Uncompensated Relationships - Minnesota Society of Health-System Pharmacists
 
Thorvardur Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Biomea Fusion; Boehringer Ingelheim; Camurus (Inst); Crinetics Pharmaceuticals (Inst); Curium Pharma; Exelixis; Ipsen (Inst); ITM Isotope Technologies Munich (Inst); Perspective Therapeutics (Inst); Tersera; Viewpoint Molecular Targeting (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Crinetics Pharmaceuticals (Inst); ITM Isotope Technologies Munich (Inst); Novartis (Inst); Perspective Therapeutics (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)
(OPTIONAL) Uncompensated Relationships - North American Neuroendocrine Tumor Society
 
Amye Tevaarwerk
Employment - Epic System (I)
Honoraria - NCCN
Other Relationship - Epic Systems (I)